Sandra Esparon
Senior Research Assistant
Working groups
Background
Sandra is a long-term member of the Immune Therapies group and has worked with Professor Hogarth since 1996.
She is part of the Cancer, Inflammation and Infectious Diseases projects which focus on antibody and Fc receptor therapeutic research and development. She also worked with Professor Geoff Pietersz from 1998 to 2014 focusing on antibody-drug conjugate therapeutic research and development.
Qualifications
- 1995: BSc, Monash University, Australia
Positions
- 2006-present: Senior Research Assistant, Burnet Institute, Australia
- 1996-2005: Research Assistant, Austin Research Institute, Australia
Burnet publications
View 13 moreStellabody: A novel hexamer‐promoting mutation for improved IgG potency
Immunological Reviews
Clarissa A. Whitehead et al
Mutation of the TGN1412 anti‐CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super‐agonist activity
Immunology and Cell Biology
Alicia M. Chenoweth et al
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
Frontiers in Immunology
Bruce D. Wines et al
Current projects
Stellabody®
Stellabody® is up to 100 times more effective at cell killing than standard antibody therapeutics.
Fc receptor targeted treatments in inflammation and allergy
We've discovered how to selectively engage and ‘switch off’ the cells that initiate and drive inflammation, targeting specific inflammatory cells in autoimmune and allergic diseases.
